The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.

dc.contributor.author	ŞENTÜRK, HAKAN
dc.contributor.author	ÖZBAY, Gülşen
dc.contributor.author	MERT, Ali
dc.contributor.author	TABAK, Ömer Fehmi
dc.contributor.author	ÖZARAS, Reşat
dc.contributor.author	Canbakan, Billur
dc.contributor.author	Akdoğan, Meral
dc.contributor.author	Tahan, Veysel
dc.date.accessioned	2021-03-06T13:07:58Z
dc.date.available	2021-03-06T13:07:58Z
dc.identifier.citation	Canbakan B., ŞENTÜRK H., TABAK Ö. F. , Akdoğan M., ÖZARAS R., Tahan V., MERT A., ÖZBAY G., "The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.", Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Chicago, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128, no.4, ss.771-772
dc.identifier.other	vv_1032021
dc.identifier.other	av_f730be19-2a56-47f4-a4a9-44c5eccd6a86
dc.identifier.uri	http://hdl.handle.net/20.500.12627/161952
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.title	The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.
dc.type	Bildiri
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	128
dc.contributor.firstauthorID	419692

Files in this item

Files	Size	Format	View
There are no files associated with this item.